Atopic Dermatitis (AD)
Conditions
Keywords
Atopic Dermatitis, Dermatology, Psychodermatology, Patient Education
Brief summary
In a previous part of this study, we created educational modules about the psychodermatology of inflammatory skin conditions, with a particular emphasis on atopic dermatitis, for patients. These modules will empower patients to better manage both the psychological and physical aspects of their skin conditions. As part of this project, we aim to conduct a clinical trial to determine the effectiveness of these modules on eczema severity and health-related quality of life in patients. We hope to use these findings to develop and disseminate accessible educational material on the psychological aspects of dermatologic care.
Interventions
BEHAVIORALPatient education modules providing information on the psychological aspects of atopic dermatitis treatment and management.
Provision of online patient educational modules (in addition to patients receiving regular clinical action/ appointments at the Kaye Edmonton Clinic, the Stollery Children's Hospital, and the Rao Dermatology Clinic for Atopic Dermatitis).
Sponsors
University of Alberta
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
4 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. New diagnosis or follow-up for previous diagnosis of Atopic Dermatitis. 2. Reliable internet access to be able to access the e-modules. 3. Able to speak English at a level required to understand the content of this study. 4. Child participants will be included in this study contingent on the consent of their guardian/caregiver(s). 5. Age range of eligible participants: Age 4 years and older.
Exclusion criteria
1. Does not have a new diagnosis or follow-up for previous diagnosis of Atopic Dermatitis. 2. Unable to access and/or navigate e-modules with reasonable support/instruction. 3. Unable to speak English at a level required to understand the content of this study. 4. Unable to provide informed consent. 5. Less than 4 years of age.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Health-Related Quality of Life | Baseline, 4 weeks, and 12 weeks | Quality of Life will be measured using the Dermatology Life Quality Index (DLQI). The scores range from 0 to 30 (higher score indicative of worse outcomes) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Eczema Disease Severity | Baseline, 4 weeks, and 12 weeks | Eczema Disease Severity will be measures using the Patient-Oriented SCORing for Atopic Dermatitis (PO-SCORAD). Scores range between 0 and 103 points (higher score indicative of worse outcomes) |
Countries
Canada
Outcome results
None listed